Form 8-K Teladoc Health, Inc. For: Jan 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Cowen Reiterates Outperform Rating on Teladoc (TDOC) Following Raised Revenue Guidance
January 10, 2022 12:51 PM ESTCowen analyst Charles Rhyee reiterated an Outperform rating and $161.00 price target on Teladoc (NYSE: TDOC) after the company raised its 2021 revenue guidance to $2.03B at an industry conference (vs. prior $2.015B-$2.025B, consensus of $2.02B), and reiterated its prelim 2022 guide of $2.6B.
Rhyee... More
